Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cellink Bioprinting AB operates within the Biotechnology & Pharmaceuticals technology area. The company has 1 pending office action currently active. This action is situated within 1 distinct art unit, indicating a concentrated technical focus for the company's current pharmaceutical innovations. The use of 1 distinct art unit allows for a specialized review of the pending matter.
The prosecution involves 1 distinct examiner. FARAZDAGHI, ARMAN MAHMOOD is the busiest examiner for the portfolio, handling 1 pending office action. This figure matches the total count of 1 pending office action for the company. Having FARAZDAGHI, ARMAN MAHMOOD as the sole examiner enables the company to tailor its strategy to the specific preferences of this individual within the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FARAZDAGHI, ARMAN MAHMOOD | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691266 | COMPOSITION FOR 3D TISSUE CULTURE | FARAZDAGHI, ARMAN MAHMOOD | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18691266 | COMPOSITION FOR 3D TISSUE CULTURE | FARAZDAGHI, ARMAN MAHMOOD | 1632 | §103§112 | Non-Final OA | — | Pending | Mar 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCellink Bioprinting AB has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Arman Mahmood Farazdaghi has the most, with 1 of Cellink Bioprinting AB's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
